1. A Single Next-Generation Sequencing (NGS) Assay for the Detection of Point Mutations and Large Chromosomal Abnormalities in MDS Patients. (April 2017) Authors: Liquori, A.; Such, E.; Palomo, L.; Moreau, S.; Pedrola, L.; Sellés, J.; Neef, A.; Zúñiga, S.; Ibáñez, M.; Company, D.; Saus, A.; Acha, P.; Sanjuan-Pla, A.; Boluda, M.; de Matteo, B.; González, E.; Sanz, M.A.; Solé, F.; Sanz, G.; Cervera, J. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CHARACTERIZATION OF TRANSCRIPTIONAL ALTERATIONS LEADING TO ABERRANT MYELOID DIFFERENTIATION IN MYELODYSPLASTIC SYNDROMES. (May 2023) Authors: Diaz-Mazkiaran, A.; De La Fuente, J.; Serrano, G.; Ainciburu, M.; García-Olloqui, P.; Berastegui, N.; Alfonso, A.; Vilas-Zornoza, A.; San-Martin, P.; Lamo-Espinosa, J.M.; Julián, M. San; Acha, P.; Solas, T. Jiménez; López-Cadenas, F.; Molero, A.; Montoro, M.J.; Solé, F.; Diez-Campelo, M.; Valcárc... Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Spanish Guidelines for the use of Targeted Deep Sequencing in MDS and CMML. (April 2017) Authors: Palomo, L.; Ibáñez, M.; Abáigar, M.; Vázquez, I.; Álvarez, S.; Cabezón, M.; Tazón-Vega, B.; Acha, P.; Benito, R.; Cervera, J.; Cigudosa, J.C.; Fuster-Tormo, F.; Hernández Sánchez, J.M.; Larrayoz, M.J.; Valcárcel, D.; Zamora, L.; Sanz, G.; Calasanz, M.J.; Solé, F.; Such, E. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Targeted Deep Sequencing of Peripheral CD34+ Cells can Reproduce Bone Marrow Molecular Profile in MDS Patients. (April 2017) Authors: Acha, P.; Martin, R.; Palomo, L.; Ganster, C.; Dierks, S.; Mallo, M.; Ademà, V.; Fuster-Tormo, F.; Gómez-Marzo, P.; De Haro, N.; Jiménez-García, F.; Solanes, N.; Zamora, L.; Xicoy, B.; Kominowski, A.; Stromburg, M.; Brockmann, A.; Truemper, L.; Sole, F.; Haase, D. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: ANALYSIS OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES USING DNA-SINGLE CELL ANALYSIS. (May 2023) Authors: Acha, P.; Maggioni, G.; Saba, E.; Riva, E.; Campagna, A.; Kordasti, S.; Palomo, L.; Mallo, M.; Calvete, O.; Della Porta, M.; Solé, F. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: CLINICAL AND MOLECULAR CHARACTERIZATION OF PATIENTS WITH THERAPY RELATED MYELOID NEOPLASMS. (May 2023) Authors: Calvete, O.; Mestre, J.; Manzanares, A.; Acha, P.; Xicoy, B.; Zamora, L.; Grau, J.; Granada, I.; Diaz, A.; Mora, E.; Such, E.; Montoro, M.J.; Valcárcel, D.; Vahí, M.; Arenillas, L.; Diez-Campelo, M.; Prosper, F.; Solé, F. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: LONGITUDINAL PREVALENCE OF CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IN BREAST AND OVARIAN CANCER PATIENTS PRIOR AND AFTER RECEIVING CYTOTOXIC TREATMENT. (May 2023) Authors: Calvete, O.; Mestre, J.; Manzanares, A.; Silverio, A.; Ruiz, R.; Aranda, J.; Acha, P.; Palomo, L.; González, A. Pérez; Bergamino, M.; Cirauqui, B.; Quiroga, V.; Felip, E.; Margeli, M.; Romeo, M.; Martinez-Cardús, A.; Teruel, I.; Solé, F. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: SINGLE-CELL MULTIOMICS ANALYSIS OF MYELODYSPLASTIC SYNDROME PREDICTS CLINICAL RESPONSE TO DNA METHYLATION INHIBITOR THERAPY. (May 2023) Authors: Campillo-Marcos, I.; Casado-Pelaez, M.; Davalos, V.; Ferrer, G.; Mata, C.; Mereu, E.; Valcárcel, D.; Molero, A.; Zamora, L.; Palomo, L.; Acha, P.; Manzanares, A.; Solé, F.; Esteller, M. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: TP53 ALLELIC STATE DID NOT INFLUENCE THE PROGNOSIS IN MYELODYSPLASTIC SYNDROMES (MDS) WITH 5Q DELETION. (May 2023) Authors: Montoro, M.J.; Palomo, L.; Haferlach, C.; Fuster-Tormo, F.; Meggendorfer, M.; Xicoy, B.; Schulz, F.; Della Porta, M.; Gonzalez, T.; López-Cadenas, F.; Acha, P.; Diez-Campelo, M.; Jerez, A.; Such, E.; Bernal, T.; Santini, V.; Platzbecker, U.; Germing, U.; Solé, F.; Haferlach, T. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling: CHARACTERIZATION OF THE TRANSCRIPTIONAL ALTERATIONS OF PATIENTS WITH DEL(5Q) MYELODYSPLASTIC SYNDROME. (May 2023) Authors: Zufiaurre, N. Berastegui; Serrano, G.; Mazkiaran, A. Díaz; Huerga, S.; García-Olloqui, P.; Ainciburu, M.; Alfonso, A.; Vilas-Zornoza, A.; Martin, P. San; De Espinosa, J.M. Lamo; Acha, P.; Solas, T. Jiménez; Molero, A.; Montoro, M.J.; Campelo, M.; Valcárcel, D.; Solé, F.; Ochoa, I.; Hernaez, M.; E... Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗